Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial

This study aimed at investigating the efficacy and safety of retrograde intrarenal surgery (RIRS) in treatment of renal pelvic stone larger than 2 cm against the percutaneous nephrolithotomy (PCNL). Between March 2018 and December 2020, 121 patients were randomized to undergo PCNL (60 patients), or...

Full description

Bibliographic Details
Main Authors: Fayad, Maged Kamal, Fahmy, Omar, Abulazayem, Khaled Mukhtar, Salama, Nashaat M.
Format: Article
Published: Springer 2021
_version_ 1825938792283897856
author Fayad, Maged Kamal
Fahmy, Omar
Abulazayem, Khaled Mukhtar
Salama, Nashaat M.
author_facet Fayad, Maged Kamal
Fahmy, Omar
Abulazayem, Khaled Mukhtar
Salama, Nashaat M.
author_sort Fayad, Maged Kamal
collection UPM
description This study aimed at investigating the efficacy and safety of retrograde intrarenal surgery (RIRS) in treatment of renal pelvic stone larger than 2 cm against the percutaneous nephrolithotomy (PCNL). Between March 2018 and December 2020, 121 patients were randomized to undergo PCNL (60 patients), or RIRS (61 patients). Both groups were compared in terms of operative time, intraoperative complications. Postoperative complications were assessed based on Clavien–Dindo grading system. Stone-free rates were evaluated by CT scan 6 weeks after surgery. No significant difference were observed between both groups in perioperative criteria. The main operative time was slightly longer in PCNL group (105 vs 95 min, p = 0.49). Stone clearance was higher in PCNL, yet the difference was not significant. (53 patients in PCNL group had either complete clearance or residual fragments < 4 mm, compared to 49 in RIRS group (p = 0.22). Blood transfusion rate was 8.3% in PCNL compared to 1.6% in RIRS group, with a trend towards significance (p = 0.08). Post-operative fever was higher in RIRS, yet it fell just short of statistical significance (13.1% vs 5.0%, p = 0.12). Compared to PCNL, RIRS displayed acceptable efficacy with less risk of bleeding requiring transfusion. It can be applied to patients with large renal pelvic stone as an alternative to PCNL.
first_indexed 2024-09-25T03:37:33Z
format Article
id upm.eprints-103076
institution Universiti Putra Malaysia
last_indexed 2024-09-25T03:37:33Z
publishDate 2021
publisher Springer
record_format dspace
spelling upm.eprints-1030762024-06-30T23:46:12Z http://psasir.upm.edu.my/id/eprint/103076/ Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial Fayad, Maged Kamal Fahmy, Omar Abulazayem, Khaled Mukhtar Salama, Nashaat M. This study aimed at investigating the efficacy and safety of retrograde intrarenal surgery (RIRS) in treatment of renal pelvic stone larger than 2 cm against the percutaneous nephrolithotomy (PCNL). Between March 2018 and December 2020, 121 patients were randomized to undergo PCNL (60 patients), or RIRS (61 patients). Both groups were compared in terms of operative time, intraoperative complications. Postoperative complications were assessed based on Clavien–Dindo grading system. Stone-free rates were evaluated by CT scan 6 weeks after surgery. No significant difference were observed between both groups in perioperative criteria. The main operative time was slightly longer in PCNL group (105 vs 95 min, p = 0.49). Stone clearance was higher in PCNL, yet the difference was not significant. (53 patients in PCNL group had either complete clearance or residual fragments < 4 mm, compared to 49 in RIRS group (p = 0.22). Blood transfusion rate was 8.3% in PCNL compared to 1.6% in RIRS group, with a trend towards significance (p = 0.08). Post-operative fever was higher in RIRS, yet it fell just short of statistical significance (13.1% vs 5.0%, p = 0.12). Compared to PCNL, RIRS displayed acceptable efficacy with less risk of bleeding requiring transfusion. It can be applied to patients with large renal pelvic stone as an alternative to PCNL. Springer 2021 Article PeerReviewed Fayad, Maged Kamal and Fahmy, Omar and Abulazayem, Khaled Mukhtar and Salama, Nashaat M. (2021) Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial. Urolithiasis, 50. pp. 113-117. ISSN 2194-7228; ESSN: 2194-7236 https://link.springer.com/article/10.1007/s00240-021-01289-9?error=cookies_not_supported&code=0b291175-6247-4345-86aa-945c463ccf3d 10.1007/s00240-021-01289-9
spellingShingle Fayad, Maged Kamal
Fahmy, Omar
Abulazayem, Khaled Mukhtar
Salama, Nashaat M.
Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title_full Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title_fullStr Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title_full_unstemmed Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title_short Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters: a prospective randomized controlled trial
title_sort retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal pelvic stone more than 2 centimeters a prospective randomized controlled trial
work_keys_str_mv AT fayadmagedkamal retrogradeintrarenalsurgeryversuspercutaneousnephrolithotomyfortreatmentofrenalpelvicstonemorethan2centimetersaprospectiverandomizedcontrolledtrial
AT fahmyomar retrogradeintrarenalsurgeryversuspercutaneousnephrolithotomyfortreatmentofrenalpelvicstonemorethan2centimetersaprospectiverandomizedcontrolledtrial
AT abulazayemkhaledmukhtar retrogradeintrarenalsurgeryversuspercutaneousnephrolithotomyfortreatmentofrenalpelvicstonemorethan2centimetersaprospectiverandomizedcontrolledtrial
AT salamanashaatm retrogradeintrarenalsurgeryversuspercutaneousnephrolithotomyfortreatmentofrenalpelvicstonemorethan2centimetersaprospectiverandomizedcontrolledtrial